Grant of Warrants

April 28, 2025
Announcement no. 14

                                                                        

Grant of Warrants

Copenhagen, Denmark, April 28, 2025, (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) has today implemented the resolution of the annual general meeting held on April 11, 2025 to issue a total of 1,700,000 warrants as part of the remuneration to members of the Board of Directors of the Company.

Each warrant entitles the holder the right to subscribe for one share in BioPorto at an exercise price of DKK 1.50 per share, corresponding to the closing price today on Nasdaq Copenhagen. The warrants are issued in accordance with section 18 a of the Articles of Association.

The warrants are subject to the terms outlined in the notice convening the annual general meeting, as set out in Company Announcement no. 9 of April 11, 2025. Under these terms, the warrants vest in equal tranches on a quarterly basis over a two-year period, with the first tranche vesting on the first day of the first calendar quarter following the date of grant. Vested warrants may be exercised until April 28, 2035.

The warrants are further governed by the Company’s incentive warrant program, as included in Appendix 1 to the Company’s Articles of Association, with certain deviations as specified in the convening notice in Company Announcement no. 9 of April 11, 2025, and the Articles of Association. The warrants include conditions on claw-back in case of e.g., erroneous financial information, and provisions on accelerated vesting in case of e.g., a takeover bid and/or business combinations.

Detailed terms of the new and existing warrants can be found in the Articles of Association on www.bioporto.com under Investor Relations> Governance> Company Articles.

The theoretical market value of the newly issued warrants is DKK 1,843,580. The calculation is based on the Black-Scholes formula using an interest rate of 2.37% and the historical volatility of BioPorto A/S’ shares over 120 months calculated to 63.82%.

To receive BioPorto’s Company Announcements, Press Releases, Newsletters and other business relevant information, please sign up on https://bioporto.com/investor-contact/.

Investor Relations Contacts